Important Information

Investors should not base on investment decisions on this material alone. Please refer to the Prospectus for details including the product features and the risk factors. Investment involves risks. Past performance is not indicative of future performance. There is no guarantee of the repayment of the principal. Investors should note:

The investment objective of Global X China Life Franklin HK-US Equity Select ETF (the “Fund”) is to provide investment results that, before fees and expenses, closely correspond to the performance of the CSI Select Market Moderate Index.
The Fund is exposed to concentration risk by tracking a specific region or country.
Underlying investments of the Fund may be denominated in currencies other than the base currency of the Fund. Investors are exposed to foreign exchange risk.
The Index constituents may be concentrated in a specific industry or sector, which may potentially more volatile than a fund with a diversified portfolio.
The Fund may invest in small and/or mid-sized companies, which may have lower liquidity and their prices are more volatile to adverse economic developments.
The Manager has delegated the investment discretion in respect of the Fund to the Sub Investment Manager. Any disruption in the communication with or assistance from the Sub-Investment Manager or a loss of service of the Sub-Investment Manager or any of its key personnel may adversely affect the operations of the Fund.
The trading price of the Fund’s unit on the SEHK is driven by secondary market trading factors, which may lead to a substantial premium or discount to the Fund’s net asset value.
The Fund’s synthetic replication strategy may invest up to 50% of its net asset value in financial derivative instruments (“FDIs”), which may expose the Fund to counterparty/credit risk, liquidity risk, valuation risk, volatility risk and over-the-counter transaction risk. The Fund may suffer losses from its usage of FDIs.
The Manager may at its discretion pay dividends out of the capital of the Fund. Distributions paid out of capital, represent a return of an investor’s original investment or its gains and may potentially reduce the Fund’s Net Asset Value per Share as well as the capital available for future investment.

Global X China Life Franklin HK-US Equity Select ETF (3428) Listed on HKEX

The Global X China Life Franklin Hong Kong–U.S. Equity Select ETF (the “Fund”) (stock codes: 3428 HKD / 83428 RMB / 9428 USD) was officially listed on Hong Kong Exchanges and Clearing Limited (HKEX).

The Fund tracks the CSI Select Market Moderate Index, which adopts a dual–engine strategy comprising 65% Hong Kong high–dividend assets and 35% U.S. leading growth companies. The index selects 45 securities from dividend–paying Hong Kong-listed companies eligible for the Southbound Stock Connect and leading non–financial U.S. firms, enabling investors to gain exposure to both Hong Kong SAR and U.S. equity markets through a single product.¹ The Fund is traded in HKD (3428), RMB (83428), and USD (9428) counters.

The listing ceremony was held today at HKEX. Guests in attendance included Ms. Judy Zhu, Chief Executive Officer of Mirae Asset Global Investments (Hong Kong) Limited; Mr. Yan Ligang, President of China Life Franklin Asset Management Company Limited; Ms. Kang Le, Vice President of China Life Insurance (Overseas) Company Limited; as well as representatives from the Securities and Futures Commission and Hong Kong Exchanges and Clearing Limited, together with a number of guests from the financial industry, who gathered to witness this important milestone.

A New Milestone in Cross–Market ETF Collaboration

Amid growing global demand for cross–market allocation tools that balance income stability and growth potential, Hong Kong equities offer a broad selection of high–dividend, cash–flow–stable blue–chip companies, while the U.S. market continues to demonstrate strong innovation momentum in areas such as artificial intelligence and semiconductors. Together, these markets form a comprehensive allocation framework spanning stable income to growth optionality.

This product combines Mirae Asset’s extensive experience in ETF product development and operations with China Life Franklin’s investment expertise across Mainland China and global markets, offering Hong Kong investors a cross–market allocation tool that integrates local insights with an international perspective.

Ms. Judy Zhu, Chief Executive Officer of Mirae Asset Global Investments (Hong Kong) Limited, said: “The launch of this ETF is intended to address investors’ allocation needs for both capital appreciation and long–term growth. Through a rules–based combination of 65% Hong Kong high–dividend stocks and 35% U.S. Leading Growth Company, we aim to provide investors with a transparent, efficient, and replicable cross–market allocation solution.”²

Mr. Yan Ligang, President of China Life Franklin Asset Management Company Limited, commented: “We are very pleased to collaborate with Mirae Asset on the launch of this innovative product. Leveraging our deep understanding of the China market and our global investment perspective, this ETF enables investors to capture both the income advantages of Hong Kong high–dividend stocks and the growth potential of leading U.S. leading growth companies, achieving a truly balanced cross–market allocation.”

Hong Kong Income and U.S. Growth — Achieved in a Single Step

The Hong Kong equity component of the Global X China Life Franklin Hong Kong–U.S. Equity Select ETF (3428 HKD / 83428 RMB / 9428 USD) focuses on high–dividend companies within the Hong Kong Stock Connect universe, spanning sectors such as banking, energy, and telecommunications, providing relatively stable cash flow. The U.S. equity component concentrates on global leaders in AI and technology, capturing long–term innovation–driven growth opportunities.^[2]

As of 27 February 2026, the index recorded a dividend yield of 3.98%, and the 3-year annualized volatility was only 13.8%, offering both attractive valuation and income potential. Back–tested data show that from 2019 to 2025, the index achieved a cumulative total return of 151.67% and an annualized total return of approximately 14.24%, outperforming pure Hong Kong SAR or U.S. markets on a risk–adjusted basis and demonstrating strong defensive characteristics during multiple market downturns.^[3]

The index undergoes quarterly mandatory rebalancing and applies a 10% single–security weight cap, using a rules–based mechanism to dynamically adjust holdings and mitigate concentration risk.³

Disclaimer

This document is for Hong Kong investors only. This document is provided for information and illustrative purposes and is intended for your use only. It is not a solicitation, offer or recommendation to buy or sell any security or other financial instrument. The information contained in this document has been provided as a general market commentary only and does not constitute any form of regulated financial advice, legal, tax or other regulated services.

Certain of the statements contained in this document are statements of future expectations and other forward-looking statements. Views, opinions and estimates may change without notice and are based on a number of assumptions which may or may not eventuate or prove to be accurate. Actual results, performance or events may differ materially from those in such statements.

Investment involves risk. Past performance is not indicative of future performance. It cannot be guaranteed that the performance of the Funds will generate a return and there may be circumstances where no return is generated or the amount invested is lost. It may not be suitable for persons unfamiliar with the underlying securities or who are unwilling or unable to bear the risk of loss and ownership of such investment. Before making any investment decision, investors should read the Prospectus for details and the risk factors. Investors should ensure they fully understand the risks associated with the Funds and should also consider their own investment objective and risk tolerance level. Investors are advised to seek independent professional advice before making any investment.

Information and opinions presented in this document have been obtained or derived from sources which in the opinion of Mirae Asset Global Investments (Hong Kong) Limited (“MAGIHK”) are reliable, but we make no representation as to their accuracy or completeness. We accept no liability for a loss arising from the use of this document.

Products, services and information may not be available in your jurisdiction and may be offered by affiliates, subsidiaries and/or distributors of MAGIHK as stipulated by local laws and regulations. This document is not directed to any person in any jurisdiction where the availability of this document is prohibited. Persons in respect of whom such prohibitions apply or persons other than those specified above must not access this document. It is your responsibility to be aware of and to observe all applicable laws and regulations of any relevant jurisdiction. Please consult with your professional adviser for further information on the availability of products and services within your jurisdiction.

This document is issued by MAGIHK (Licensed by the Securities and Futures Commission for Types 1, 4 and 9 regulated activities under the Securities and Futures Ordinance). This document has not been reviewed by the Securities and Futures Commission or the applicable regulator in the jurisdiction in which this article is posted and no part of this publication may be reproduced in any form, or referred to in any other publication, without express written permission of MAGIHK.

Important Information

Global X China Life Franklin HK-US Equity Select ETF (3428) Listed on HKEX

Related ETFs